A Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Clinical trial NCT04460820 · COMPLETED
Trial details
- NCT number
- NCT04460820
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-04
- Primary completion
- 2019-12-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.